You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Epidermal

Showing 1 - 25 of 3,750
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Autologous Epidermal Cell Transplantation Trial (Cultured autologous epidermal cell membrane)

Not yet recruiting
  • Autologous Epidermal Cell Transplantation
  • Cultured autologous epidermal cell membrane
  • (no location specified)
May 31, 2023

Temporomandibular Joint Disorders Trial in Alexandria (Nd-YAG Fotona, Epidermal Growth Factor)

Enrolling by invitation
  • Temporomandibular Joint Disorders
  • Nd-YAG Fotona
  • Epidermal Growth Factor
  • Alexandria, الإسكندرية, Egypt
    Alexandria University
Sep 13, 2023

Toxic Epidermal Necrolysis Trial in Fuzhou (Abrocitinib)

Recruiting
  • Toxic Epidermal Necrolysis
  • Fuzhou, Fujian, China
    Department of Dermatology, the First Affiliated Hospital of Fuji
Oct 31, 2023

Vitiligo Trial in Nice (Ruxolitinib Topical, Placebo)

Not yet recruiting
  • Vitiligo
  • Ruxolitinib Topical
  • Placebo
  • Nice, Alpes-maritimes, France
    CHU de Nice - Hôpital de l'Archet
May 22, 2023

Advanced or Metastatic NSCLC Harboring Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion (ex20ins) Mutations Trial in

Recruiting
  • Advanced or Metastatic NSCLC Harboring Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion (ex20ins) Mutations
  • Canton, Ohio
    Gabrail Cancer and Research Center
Jul 21, 2023

Aging Trial in Bangkok (Epidermal Growth Factor)

Active, not recruiting
  • Aging
  • Epidermal Growth Factor
  • Bangkok, Thailand
    Institute of Dermatology
Feb 9, 2023

Recurrent Glioblastoma Trial (Targeted Epidermal Growth Factor Receptor Variant III(EGFRvIII) autochimeric antigen receptor T

Not yet recruiting
  • Recurrent Glioblastoma
  • Targeted Epidermal Growth Factor Receptor Variant III(EGFRvIII) autochimeric antigen receptor T cell injection
  • (no location specified)
Apr 4, 2023

NSCLC (NSCLC) Trial (Osimertinib, Amivantamab)

Not yet recruiting
  • Non-Small Cell Lung Cancer (NSCLC)
  • (no location specified)
Mar 24, 2023

Chronic Pain, Opioid Use, and Epidermal Nerve Fiber Density

Recruiting
  • Chronic Pain
  • +2 more
    • Kansas City, Kansas
      University of Kansas Health System
    Jun 14, 2022

    Neuropathy;Peripheral Trial in Houston (Abbott® DRG / Abbott®/Medtronic® SCS, Control Group)

    Recruiting
    • Neuropathy;Peripheral
    • Abbott® DRG / Abbott®/Medtronic® SCS
    • Control Group
    • Houston, Texas
      M D Anderson Cancer Center
    Nov 2, 2023

    Junctional Epidermolysis Bullosa Trial in Salzburg (Transplantation surgery of genetically corrected cultured epidermal

    Terminated
    • Junctional Epidermolysis Bullosa
    • Transplantation surgery of genetically corrected cultured epidermal autograft (ATMP)
    • Salzburg, Austria
      EB House Austria, Department of Dermatology, Paracelsus Medical
    Feb 18, 2022

    Breast Cancer Trial in Sarasota, Nashville (AC699)

    Recruiting
    • Breast Cancer
    • Sarasota, Florida
    • +1 more
    Jan 3, 2023

    Chronic Ulcer of Lower Extremity Trial in Germany (CPtcube, CPTpatch)

    Recruiting
    • Chronic Ulcer of Lower Extremity
    • CPtcube, CPTpatch
    • Tübingen, Baden-Württemberg, Germany
    • +7 more
    May 3, 2023

    Recessive Dystrophic Epidermolysis Bullosa Trial in Salzburg (Genetically corrected cultured epidermal autograft (ATMP))

    Terminated
    • Recessive Dystrophic Epidermolysis Bullosa
    • Genetically corrected cultured epidermal autograft (ATMP)
    • Salzburg, Austria
      EB House Austria, Department of Dermatology, Paracelsus Medical
    Feb 15, 2022

    Advanced or Metastatic NSCLS With Exon 20 Insertion Mutation Trial in Canton (TAS6417)

    Recruiting
    • Advanced or Metastatic NSCLS With Exon 20 Insertion Mutation
    • Canton, Ohio
      Gabrail Cancer and Research Center
    Jul 25, 2023

    Inflammatory Epidermal Genodermatoses Trial in Nice (deucravacitinib)

    Not yet recruiting
    • Inflammatory Epidermal Genodermatoses
    • Nice, Chu de Nice, France
      DRCI
    Nov 24, 2023

    Breast Cancer Invasive Trial (pyrotinib)

    Not yet recruiting
    • Breast Cancer Invasive
    • (no location specified)
    Jun 18, 2023

    Scar Trial in Pittsburgh (5-0 Polypropylene epidermal suture, 5-0 Fast gut epidermal suture)

    Recruiting
    • Scar
    • 5-0 Polypropylene epidermal suture
    • 5-0 Fast gut epidermal suture
    • Pittsburgh, Pennsylvania
    • +2 more
    Oct 6, 2022

    Epidermal Nevi, Nevus Sebaceus Trial in Redwood City (NFX-179 Gel 1.50%)

    Not yet recruiting
    • Epidermal Nevi
    • Nevus Sebaceus
    • NFX-179 Gel 1.50%
    • Redwood City, California
      Stanford University
    Mar 22, 2022

    Brain Metastases, Human Epidermal Growth Factor 2 Positive Carcinoma of Breast, Advanced Breast Cancer Trial (Trastuzumab,

    Recruiting
    • Brain Metastases
    • +2 more
    • Saint Louis, Missouri
    • +1 more
    Nov 8, 2022

    OPTImal PALliative Anti-epidermal Growth Factor Receptor

    Active, not recruiting
    • Colorectal Cancer Metastatic
    • +5 more
    • Plasma circulating DNA analysis
    • Aarhus, Denmark
      Aarhus University Hospital
    Feb 24, 2022

    Blister, Wound of Skin Trial in Lund (TCP-25 gel 0.86 mg/ml or gel, TCP-25 gel 2.9 mg/ml or gel, TCP-25 gel 8.6 mg/ml or gel)

    Active, not recruiting
    • Blister
    • Wound of Skin
    • TCP-25 gel 0.86 mg/ml or placebo gel
    • +2 more
    • Lund, Sweden
      Skåne University Hospital in Lund, Clinical Trial Unit
    Dec 7, 2022

    Melasma Trial in Bandung (10% Curcuma xanthorriza Roxb., 2% Kojic Acid)

    Recruiting
    • Melasma
    • 10% Curcuma xanthorriza Roxb.
    • 2% Kojic Acid
    • Bandung, West Java, Indonesia
      Hasan Sadikin General Hospital
    Nov 22, 2023

    Acneiform Eruption Due to Chemical, Xerosis Cutis, Paronychia Trial (HT-001 2% Topical Gel, HT-001 1% Topical Gel, HT-001 0.5%

    Not yet recruiting
    • Acneiform Eruption Due to Chemical
    • +2 more
    • HT-001 2% Topical Gel
    • +3 more
    • (no location specified)
    Dec 3, 2022

    Stevens-Johnson Syndrome, Toxic Epidermal Necrolyses Trial in Nashville (Harmonized supportive care, Cyclosporine 5 mg/kg bid

    Not yet recruiting
    • Stevens-Johnson Syndrome
    • Toxic Epidermal Necrolyses
    • Harmonized supportive care
    • +2 more
    • Nashville, Tennessee
      Vanderblt University Medical Center
    Dec 29, 2022